Teladoc buys mental health company UpLift to help boost struggling BetterHelp unit

Teladoc buys mental health company UpLift to help boost struggling BetterHelp unit


Teladoc Health Inc. signage on the floor of the New York Stock Exchange on Dec. 31, 2024.

Michael Nagle | Bloomberg | Getty Images

Virtual care provider Teladoc Health, which has seen its market value plummet over the past five years, said Wednesday that it acquired mental health company UpLift for $30 million in cash.

Teladoc said the acquisition will help the company build out its struggling BetterHelp mental health segment. Revenue at BetterHelp declined 10% to about $250 million in 2024, and has faced challenges since the economy started reopening after the Covid pandemic.

UpLift, which offers virtual mental health therapy, psychiatry and medication management services, generated around $15 million in revenue last year, Teladoc said.  

“BetterHelp was founded to remove the traditional barriers to therapy and make mental health care more accessible to everyone,” BetterHelp President Fernando Madeira said in a statement. “We believe joining forces with UpLift will help us advance that mission — especially for those seeking to use their coverage benefits — while also driving topline revenue growth that will help sustain and expand our impact over time.”

Teladoc said the deal closed Wednesday, and UpLift will be factored into the BetterHelp segment going forward.

Don’t miss these insights from CNBC PRO

Shares of Teladoc fell more than 2% in extended trading. The company also announced its first-quarter results after market close, reporting revenue of $629.4 million, down 3% year-over-year. Teladoc reported a net loss of $93.0 million, or a 53-cent loss per share.

The UpLift acquisition comes two months after Teladoc announced plans to buy preventative care company Catapult Health, which offers an at-home wellness exam, for $65 million.

Teladoc CEO Chuck Divita has been working to turn the company around after four-straight quarters of declining revenue and an extended slump in the stock price. When Teladoc acquired digital health company Livongo in 2020, it had a combined enterprise value of $37 billion. In early 2022, Teladoc took a write-down of about $6.6 billion tied to the Livongo deal.

Teladoc now has a market capitalization of just over $1 billion. The stock has fallen about 20% this year.

WATCH: Interview with Teladoc CEO

Teladoc Health CEO Jason Gorevic on positive Q1 earnings results



Source

Abortion pill makers brace for restrictions a year after Trump’s election
Health

Abortion pill makers brace for restrictions a year after Trump’s election

Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe […]

Read More
Republicans push Obamacare tax credit alternatives as enrollment deadline looms
Health

Republicans push Obamacare tax credit alternatives as enrollment deadline looms

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025 in Miami, Florida. Joe Raedle | Getty Images With enhanced Obamacare tax credits set to expire at the end of the year, Republicans are proposing new alternatives aimed at lowering the cost of health care. Their window for doing so is rapidly […]

Read More
Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target
Health

Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty Images Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal. The trial tested whether semaglutide — the […]

Read More